In a global perspective, depression is the leading cause of ill health and disability. More than 264 million people are affected and at least 25 percent of all women and 15 percent of all men experience a depression that ...
Jun 12, 2023
0
43
University of Virginia School of Medicine researchers have identified a key contributor to high blood pressure that could lead to new treatments for a condition that affects almost half of American adults.
Oct 12, 2022
0
39
Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant ...
Jun 11, 2021
0
2
There are immune cells in our bodies that directly destroy infected or cancer cells—they are called natural killer cells. Recently, a POSTECH research team has developed an integrative cancer therapy using adoptive natural ...
May 13, 2020
0
12
Wegovy, Mounjaro, Ozempic... These new drugs drawing such intense attention have raised the hopes of millions around the world suffering from diabetes or obesity. But what are they, how are they used and who makes them?
Dec 4, 2023
0
0
Urinary tract infections are common and usually simple to treat. But for people who become sick enough to land in the hospital with one, an experimental antibiotic may soon offer a new treatment option—taken by mouth instead ...
Apr 7, 2022
0
7
A review of the COVID-19 vaccine trials indicate that adenovirus vectored vaccines may have non-specific protective effects resulting in significantly reduced all-cause mortality and non-COVID deaths, compared with mRNA based ...
Jan 19, 2023
0
4
A team of medical researchers with affiliations to British multinational pharmaceutical and biotechnology company GlaxoSmithKline (GSK) has found that a new antibiotic drug the company developed to treat urinary tract infections ...
When Professor Yan Liu was growing up in Changchun, China, her father wanted her to become a doctor like him. When she chose computer science, "I was a tiny bit disappointed," Xiwen Liu, a retired anesthesiologist, acknowledges.
Apr 5, 2023
0
4
A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid receptor type 2 (CB2) agonist that triggers the resolution of inflammation, to treat amyopathic dermatomyositis. ...
Sep 21, 2022
0
2
